Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine and Ascorbic Acid in Adult Sepsis Patients
NCT07786350Completed
- Sponsor
- Universitas Sumatera Utara
- Start
- Apr 2020
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Randomised, open-label trial of thiamine and ascorbic acid in sepsis and septic shock (4 arms), sponsored by Universitas Sumatera Utara. Primary endpoints: Change in serum Matrix Metalloproteinase-9 concentration at 72 hours, Change in serum Tissue Inhibitor of Metalloproteinase-1 concentration at 72 hours and 1 more. Started Apr 2020; status: completed.
02
Drugs
thiamineascorbic acid
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT07786350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07786350.